Countries average performance (HIV, TB, and Malaria) since 2010
The Global Fund achievement in fighting HIV, TB and Malaria
HIV, TB and Malaria prevalence in 2013
The Global fund and the MENA region

GFO Articles

On 20 March 2017, Zanzibar submitted a TB/HIV program continuation request for $6.4 million. Of this amount, just over $0.5 million was a prioritized above allocation request (PAAR), details of which will be presented only during the grant-making stage. The Ministry of Health is the sole...

27 Apr 2017

As GFO reported a few weeks ago, Zimbabwe submitted a TB/HIV funding request for $629 million in Window 1 of the current funding cycle. The $629 million request consisted of $432 million that was within Zimbabwe’s allocation, and $197 million for a prioritized above-allocation request (PAAR)....

27 Apr 2017

On 20 March 2017, the deadline for applications in Window 1 of the current funding cycle, the Uganda country coordinating mechanism (CCM) submitted a funding request containing three components: TB/HIV, malaria and RSSH (resilient and sustainable systems for health). The CCM also submitted a...

27 Apr 2017

More needs to be done to promote the inclusion of operational and implementation research (OR/IR) initiatives in funding requests to the Global Fund. The Secretariat, technical partners and countries all have a role to play in making this happen.


This was the central message of a...

19 Apr 2017

The Global Fund Board has approved an extension of an existing malaria grant to Nigeria as well as a new one-year grant with a new principal recipient (PR) – all at no extra cost. The extension and the new grant will be financed by reinvesting savings identified in Nigeria’s current malaria...

18 Apr 2017

Aidspan is a non-profit organization based in Kenya whose mission is to reinforce the effectiveness of the Global Fund to Fight AIDS, Tuberculosis and Malaria by serving as an independent watchdog of the Fund and its grant implementers

Examining the trends in costs of medicines for drug-susceptible and drug-resistant tuberculosis from 2010 - 2013; an analysis of Global Fund PQR data
15 Jan 2015

The paper examines the trends in costs of medicines to treat drug susceptible and drug-resistent tuberculosis. The trends include a comparison between the High Burden Countries, as categorized by WHO, and the other countries that all receive or have received Global Fund support.

Pages